The nuclear expression of the small heat shock protein – alpha B crystalline as a marker for poor prognosis in NSCLC patients

R. Cherneva, O. Georgiev, I. Dimova, D. Borisov, D. Toncheva, M. Stamenova, V. Vlasov, N. Trifonova (Sofia, Bulgaria)

Source: Annual Congress 2009 - Basic science and lung cancer
Session: Basic science and lung cancer
Session type: Oral Presentation
Number: 3072
Disease area: Thoracic oncology

Congress or journal article abstractSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Cherneva, O. Georgiev, I. Dimova, D. Borisov, D. Toncheva, M. Stamenova, V. Vlasov, N. Trifonova (Sofia, Bulgaria). The nuclear expression of the small heat shock protein – alpha B crystalline as a marker for poor prognosis in NSCLC patients. Eur Respir J 2009; 34: Suppl. 53, 3072

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Inhibitor of DNA-binding (Id) – 1 and 3 proteins overexpression has impact on prognosis of lung adenocarcinoma
Source: Annual Congress 2011 - Progress in pathology of lung cancer
Year: 2011


Heat shock protein (HSP) 72 polymorphism in small cell lung cancer (SCLC) patients
Source: Eur Respir J 2005; 26: Suppl. 49, 330s
Year: 2005

Heat shock protein expression in small cell lung cancer (SCLC)
Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology
Year: 2007


Hypoxia inducible factor-1 alpha (HIF-1 alpha) expression was correlated with the survival in patients with small cell lung cancer (SCLC)
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010

Tissue expression of alpha crystallins and plasma levels of antibodies against them in NSCLC patients – Prognostic significance
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010


Nuclear expression of Y-Box binding protein (YB-1) as a negative prognostic marker in non-small cell lung cancer
Source: Annual Congress 2003 - Lung cancer biology
Year: 2003


Overexpression of inhibitor of DNA-binding proteins and angiogenic markers have higher impact on survival of non small cell lung cancer patients
Source: Annual Congress 2012 - New insights in the pathology of lung cancer
Year: 2012


Nuclear YB-1 expression as a negative prognostic marker in nonsmall cell lung cancer
Source: Eur Respir J 2004; 23: 14-19
Year: 2004



Espression of vascular endothelial growth factor (VEGF) and its receptors (VEGF-R1-Flt1, VEGF-R2-Flk1) in non small cell (NSCLC) and small cell lung carcinomas (SCLC). Correlation with clinical outcome
Source: Annual Congress 2008 - Biology in thoracic tumours
Year: 2008


Globo h tumor antigen expression is associated with blood group a1 and negative prognosis in NSCLC
Source: Annual Congress 2009 - Lung cancer biology
Year: 2009


Carbonic anhydrase 9 expression (CA9e) profile combined with growth patterns (GPs) in non-small cell lung cancer (NSCLC) identifies a group of patients with an extremely poor prognosis
Source: Annual Congress 2005 - New insights into prognosis in thoracic surgical oncology
Year: 2005


EGFR and hTERT mRNA expression in non-small cell lung cancer patients – Diagnostic and prognostic implications
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010


Akt induced cytoplasmic mislocalization of p27kip1 protein and correlated with poor prognosis in lung adenocarcinoma
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008


Expression of vascular endothelial growth factor (VEGF) and its receptors (VEFG-R1-Flt1, VEGF-R2-Flk1) in non small cell lung carcinomas (NSCLC): correlation with lymphangiogenesis and clinical outcome
Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology
Year: 2007


EGFR and hTERT expression in high risk COPD patients – clinical application
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009

Characteristics and prognostic relevance of p53 gene mutations in Polish non small cell lung cancer (NSCLC) patients
Source: Eur Respir J 2005; 26: Suppl. 49, 92s
Year: 2005

LATE-BREAKING ABSTRACT: A mRNA signature predicts outcome of patients (pts) with advanced non small cell lung cancer (NSCLC) treated with cisplatin (C) and vinorelbine (V): A ELCWP prospective study
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012


Expression of Fhit protein in non-small cell lung cancer (NSCLC) and its correlation with Ki-67, a proliferative marker
Source: Eur Respir J 2002; 20: Suppl. 38, 230s
Year: 2002

Increased expression of heat shock protein 70 in COPD
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010

The significance of T-box transcription factor 5 and CD44s expression in NSCLC: correlation with prognostic markers.
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018